Displaying 1-7 of 7 result(s).
| Board Name | Posts By Home Run | Post Created |
|---|---|---|
| SIZZLING STOCK PICKS | PMBS an Absolutely Great MMJ Stock | 10/12/2014 9:32:15 PM |
| Coffee Shoppe | PMBS Steady Growth - Ready to Run h | 10/12/2014 9:26:15 PM |
| Investors Hangout MVP's | PMBS Very Bullish $$$$ http://www.p | 10/12/2014 9:22:00 PM |
| MJ Cannabis Companies | PMBS The Next Big MMJ Winner http:/ | 10/12/2014 9:18:43 PM |
| Matrix Investment Group / OTCmatrix | PMBS Looks Like a Huge Winner http: | 10/12/2014 9:15:39 PM |
| BREAKOUTS..RUNNERS AND HOT PENNIES | PMBS MMJ Bounce Alert http://www.pu | 10/12/2014 9:11:11 PM |
| The Hunt for the Next 10 Bagger | PMBS Looking Good Here PMBS Watch T | 10/12/2014 9:06:15 PM |
Recent Articles
- Plymouth Industrial REIT's Strong Finish and Future Outlook
- Next Health Expands Its Vision with New Nashville Location
- Señorita Partners with Salt Shed to Revolutionize Concert Experiences
- Spero Therapeutics Appoints New Interim Leadership and Update on Trials
- Experience Unmatched Audio with Cooler Master's CH351 Headset
- Bio-Path Holdings Reveals 2025 Strategy for Cancer Treatments
- Recent Developments for Aspo: Board Member Charges Dropped
- Quanterix and Akoya Merger: A Game Changer in Biomarker Detection
- EDAP TMS Strengthens Board with Joshua H. Levine's Appointment
- New Leaders Bring Fresh Energy to RMHC Bay Area Board
- Immunocore Sets Ambitious Goals for 2025 at Industry Conference
- Chemtrade Logistics Welcomes New Board Member: Suzann Pennington
- Leadership Transition at NeoGenomics as Chris Smith Retires
- Significant Milestones for GH Research in Psychiatric Trials
- Arvinas Unveils New Developments and Future Plans for Trials
- The New York Stem Cell Foundation's Innovative Drug Discovery Partnership
- BioCryst Pharmaceuticals Reports Strong Revenue Growth for ORLADEYO
- D-Wave Quantum Inc. Reports Increased Bookings of $23 Million
- Marengo Therapeutics to Showcase Advances at Healthcare Event
- Invivyd Reports Strong Neutralizing Effect of PEMGARDA™ Against New COVID Variants
- Discover Pairzon's Revolutionary Marketing Optimization Tool
- Xeris Biopharma Anticipates Record Revenue Growth for 2024
- Y-mAbs Announces Strategic Shift and Future Milestones Ahead
- Aktis Oncology's Presentation at Major Healthcare Conference
- Compass Pathways Sets Pricing for American Depositary Shares Offering
- HBT Financial Set to Reveal Q4 2024 Results Soon
- Mediar Therapeutics and Lilly Collaborate on Breakthrough IPF Treatment
- Cipia-FS10 Introduces Advanced Driver Assistance for Fleets
- AtlasClear Holdings Looks Ahead: A New Era for Growth
- Tel-Aviv Stock Exchange Expands Growth with Share Buyback
- CI Financial Advances Shareholder Voting with Special Meeting
- nsave Introduces Innovative Investment Platform for Global Clients
- Chemtrade Aims High with 2025 Guidance and Distribution Boost
- Exciting Culinary Trends Shaping Beef Cooking in 2025
- Branford Castle Partners Expands Portfolio with Eastern Dental
- Bio-Techne Enhances Designer Protein Line for Regenerative Medicine
- Neogen Corporation Reveals Preliminary Q2 Financial Metrics
- Aircastle Limited Reports Strong Financial Performance
- Aurora Cannabis Empowers Future Leaders with New Internship
- Nektar Therapeutics' Phase 2b Trial Enrollment Completes for AD
- Simplifying Tax Filing with ez1099 2024 for Businesses
- Top Franchises Recognition for Five Star Franchising Brands
- Innovative Competition Targets Groundbreaking Cancer Research Efforts
- Pfizer's Sasanlimab Shows Promise in Bladder Cancer Treatment
- Legacy of Ronald S. Lauder: Transition at The Estée Lauder Companies
- Avery Dennison Readies for Fourth Quarter Earnings Call in 2025
- Lindsay Corporation Declares Cash Dividend for Shareholders
- Intra-Cellular Therapies Reaches Settlement Over CAPLYTA Patent
- Astronics Corporation Reports Revenue Growth and Future Outlook
- Dyne Therapeutics Advances DYNE-101 for Myotonic Dystrophy